Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × balstilimab × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 10 Stomach Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 2 Neoplasm Metastasis 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Sarcoma 1 Resectable MMR-deficient Solid Tumors 1 Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) 1 Pancreatic Cancer Metastatic 1 Oropharyngeal Neoplasms 1 Microsatellite Stable Rectal Carcinoma 1 Lymphoma 1 Glioma 1 Esophageal Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Cancer Metastatic 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Advanced Solid Tumor 1 Advanced Renal Cell Carcinoma 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

pembrolizumab 119 Cisplatin 70 Cetuximab 52 Carboplatin 46 Nivolumab 39 Paclitaxel 38 Docetaxel 33 Radiotherapy 32 Radiotherapy, Intensity-Modulated 23 Fluorouracil 19 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 Taxes 11 durvalumab 10 cemiplimab 10 Radiation 10 Platinum 10 Ipilimumab 10 1,2-diaminocyclohexaneplatinum II citrate 10 atezolizumab 9 Drug Therapy 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Surgical Procedures, Operative 7 Standard of Care 7 Chemoradiotherapy 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 toripalimab 6 avelumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡